Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contracting for professional service agreements

M L Berman1

  • 1Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange 92613, USA.

Gynecologic Oncology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant eccrine spiradenoma of the vulva: a case report and review of the literature.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

Surgical management of epithelial ovarian cancer: a review of the literature.

Minerva ginecologica·2005
Same author

HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

British journal of cancer·2003
Same author

A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Obstetrics and gynecology·2001
Same author

Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy.

Cancer·2001
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Physicians should carefully review managed care contracts, understanding both financial benefits and practice restrictions. Evaluating professional service agreements (PSA) as business transactions is crucial for protecting clinical practice.

Area of Science:

  • Health Policy
  • Medical Economics
  • Oncology Practice Management

Background:

  • Managed care organizations (MCOs) increasingly contract with healthcare providers.
  • Professional Service Agreements (PSAs) govern these relationships, impacting physician practices.
  • Gynecologic oncologists in Southern California face specific contractual terms.

Purpose of the Study:

  • To analyze patterns in PSAs between MCOs and gynecologic oncologists.
  • To guide physicians in evaluating and negotiating these critical business contracts.
  • To identify potential practice restrictions and financial benefits within these agreements.

Main Methods:

  • Review of multiple Professional Service Agreements (PSAs) from MCOs.
  • Analysis of contractual terms affecting gynecologic oncology practices in Southern California.

Related Experiment Videos

  • Identification of common advantages and disadvantages in MCO contracts.

    • Main Results:

    • PSAs present both opportunities for increased referrals and income, and risks of practice restrictions.
    • Key disadvantages include impacts on overhead, efficiency, and quality of care delivery.
    • Specific contract clauses require careful scrutiny to avoid negative consequences.

    Conclusions:

    • Physicians must treat PSAs as significant business transactions, evaluating them thoroughly.
    • Key recommendations include avoiding 'hold harmless' clauses and ensuring verbal agreements are in writing.
    • Physicians should avoid contracts leading to unsustainable practice growth and potential antitrust issues.